Weight loss · Lenexa, KS
Weight loss and obesity studies in Lenexa, KS
6 recruiting studies have a site in Lenexa.
6 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
2 studies with pay posted
Exact amounts posted by the research company for each study. The button opens that study’s own page.
Pays up to
$10,500
Clinical Research Study of an Investigational Medication in Overweight but Otherwise Healthy Participants
ICON · Lenexa, KS
Participation in this study includes 1 screening visit, 1 stay of 6 nights and 6 outpatient visits.
Ages 18–55 · Male/Female · Non Smoker
View study & apply (opens in a new tab)Opens ICON’s page for this exact study
Pays up to
$7,750
Clinical Research Study of an Investigational Medication in Overweight but Otherwise Healthy Volunteers
ICON · Lenexa, KS
Participation in this study includes 1 screening visit, 1 stay of 13 nights and 1 follow-up visit.
Ages 18–55 · Male/Female · Non Smoker
View study & apply (opens in a new tab)Opens ICON’s page for this exact study
More recruiting studies (pay not posted)
- RecruitingHealthy volunteersPhase 1
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Novo Nordisk A/S
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
Novo Nordisk A/S
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Amgen
- Location
- Lenexa, KS + 30 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Amgen
- Location
- Lenexa, KS + 69 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
AstraZeneca
- Location
- Lenexa, KS + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Amgen
- Location
- Lenexa, KS + 117 other US sites
- Eligibility basics
- Ages 18–99
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.